HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jikang Jiang Selected Research

fluchloralin

1/2019A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus.
1/2018Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jikang Jiang Research Topics

Disease

2Hypoglycemia (Reactive Hypoglycemia)
01/2019 - 01/2018
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Diabetes Mellitus
01/2018

Drug/Important Bio-Agent (IBA)

2fluchloralinIBA
01/2019 - 01/2018
2Insulin Glargine (Lantus)FDA Link
01/2019 - 01/2018
2Blood Glucose (Blood Sugar)IBA
01/2019 - 01/2018
2Insulin (Novolin)FDA Link
01/2019 - 01/2018
2Biosimilar PharmaceuticalsIBA
01/2019 - 01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019